
Sharon R. Flanagan
Capital Markets
Global Governance
Global Life Sciences
Technology
Biography
SHARON FLANAGAN is a member of the firm’s Management and Executive Committees and the managing partner of the firm’s San Francisco office. Sharon has over 25 years of experience representing innovative companies and investors in the life sciences and technology industries in a wide range of strategic transactions, including public and private mergers and acquisitions, spin-offs, joint ventures, minority and controlling investments, and securities offerings. Sharon also advises public companies on corporate governance, SEC disclosure and compliance, and shareholder activism.
Sharon has been recognized by the Daily Journal as one of the “Top 100 Lawyers in California,” most recently in 2025, and was also recognized in Lawdragon’s “500 Leading Dealmakers in America” 2027 guide. She has been recognized by LMG Life Sciences as a “Life Sciences Star” in the Mergers & Acquisitions category (2018–2024). She was selected by The Recorder as one of “10 Power Players” in California as lawyers who stand out as “trailblazers, mentors and advocates for women in tech.”
Chambers USA has ranked Sharon for 15 years, including Corporate/M&A (California: San Francisco, Silicon Valley, 2020–2026), Capital Markets: Debt & Equity: Western United States (Nationwide, 2019–2026), Capital Markets: Debt & Equity (California, 2013–2026), and Life Sciences: Corporate/Commercial (California, 2026). Clients describe Sharon as “a brilliant negotiator” who “provides commercial… plain-English advice” (Chambers USA 2025). She has also been recognized in the 2011 through 2022 editions of The Best Lawyers in America for Corporate Law, M&A Law and Corporate Compliance Law.
Sharon is a trustee and member of the Executive Committee of the board of The Exploratorium, a leading science museum based in San Francisco.
Experience
Representative Matters
Notable transactions include representing the following:
Life Sciences and Healthcare
- F. Hoffmann-La Roche Ltd in its acquisition of 89bio, Inc. (Nasdaq: ETNB), a biopharmaceutical company focused on therapies for the treatment of liver and cardiometabolic diseases, for up to US$3.5 billion in cash and contingent value rights.
- GE HealthCare Technologies Inc. in its US$945 million acquisition of SOFIE Biosciences, a radiopharmaceutical company with a U.S. network of contract manufacturing organization sites.
- Telix Pharmaceuticals Limited in its US$1.65 billion acquisition of ITM Isotope Technologies Munich SE, a Germany-based radiopharmaceutical company specializing in radioisotope production and radiopharmaceutical development, with additional contingent consideration of up to US$700 million.
- GE HealthCare in its US$2.3 billion acquisition of Intelerad, a medical imaging software provider offering cloud and AI orchestration capabilities.
- Roche in its acquisition of Poseida Therapeutics (Nasdaq: PSTX), a specialist in CAR-T immune cell therapies, for US$1.5 billion in cash and contingent value rights.
- Roche in its acquisition of Carmot Therapeutics Inc., a clinical-stage GLP-1 company, for an upfront payment of US$2.7 billion and additional milestone payments of up to US$400 million.
- Genentech, Inc. in its sale of a biologics manufacturing facility to contract drug manufacturer Lonza for US$1.2 billion in cash.
- DaVita, Inc. in the formation of Mozarc Medical, its medical device joint venture with Medtronic focused on developing a broad suite of novel kidney care products and solutions.
- Roche in its acquisition of diagnostics company GenMark (Nasdaq: GNMK) for US$1.8 billion in cash.
- Roche in its acquisition of Ignyta, Inc. (Nasdaq: RXDX), a cancer therapy company, for US$1.7 billion in cash, which LMG Life Sciences named as one of its “Deals of the Year.”
- Fortive Corporation in its acquisition of the Advanced Sterilization Products business from Johnson & Johnson for US$2.8 billion in cash in a transaction structured as a binding offer.
- Roche in its acquisition of ForSight VISION4, a biotechnology company focused on drug delivery for treatment of retinal diseases.
- Genentech in its acquisition of Seragon Pharmaceuticals, Inc., a biotechnology company focused on the treatment of breast cancer, for up to US$1.725 billion in cash.
- Roche Molecular Systems in its acquisition of Genia Technologies, a DNA sequencing company, for US$125 million in cash and up to US$225 million in milestones.
- Medivation in its acquisition of a Phase III PARP inhibitor program from BioMarin for US$570 million.
- Hansen Medical in its sale to Auris Surgical Robotics which was later acquired by Johnson & Johnson.
- Roche in its acquisition of genomics software company BINA Technologies Inc.
- Genentech in its acquisition of NLRP3 inhibitor development-stage company Jecure Therapeutics.
- Roche in multiple options to acquire companies, including its collaboration and option to acquire Versant incubator, Inception 3, an early stage hearing loss development program and Inception 5, an early stage multiple sclerosis development program; its collaboration and option to acquire epigenetic company, Constellation Pharmaceuticals; and its collaboration and option to acquire Forma Therapeutics, a development-stage oncology company.
- Genentech in its purchase from Lonza of a biologic manufacturing facility in Singapore and sale of a biologic manufacturing facility to Lonza in Spain.
- Baxter International Inc. in the formation and spinoff of its worldwide cardiovascular business to Edwards Lifesciences.
- GE Medical Systems in the sale of its global radiotherapy service business to Varian Medical Systems.
- DaVita in multiple high-yield notes offerings, including its acquisition financing for HealthCare Partners.
- The underwriters for multiple equity and debt offerings by healthcare REIT, Healthpeak Properties, Inc.
Technology
- ServiceTitan, Inc. in its acquisition of Schedule Engine, a leading provider of online booking for home and commercial services.
- ServiceTitan in its acquisition of FieldRoutes, a cloud-based and mobile SaaS provider in the pest control and lawn care industry.
- ServiceTitan in its acquisition of Aspire Software, a landscaping business management software provider.
- Flex Ltd. in its sale of US$500 million of convertible preferred equity in its solar tracker subsidiary, Nextracker Inc. to TPG Rise Climate, the initial public offering of Nextracker’s Class A common stock, and the spinoff of its remaining interests in Nextracker to the Flex shareholders.
- ContextLogic, an eCommerce company that operates the Wish platform, in its sale of substantially all of its assets to Singapore-based Qoo10 for US$173 million.
- Palo Alto Networks, Inc. in its acquisition of cloud-delivered SD-WAN provider, CloudGenix Inc., for US$420 million.
- Palo Alto Networks in its acquisition of cloud native security platform, Twistlock, for US$410 million in cash.
- Palo Alto Networks in its acquisition of cybersecurity company, Demisto, for US$560 million in cash and stock.
- Palo Alto Networks in its acquisition of serverless security company, PureSec.
- Splunk Inc. in its acquisition of cloud monitoring leader SignalFx for US$1.05 billion in cash and stock.
- Splunk in its acquisition of Phantom Cyber, a cybersecurity company, for US$350 million.
- PayPal Inc. in its acquisition of Xoom Corporation (NASDAQ: XOOM), a leading international digital money transfer provider, for US$890 million in cash.
- PayPal in its acquisition of Braintree, operator of the Braintree and Venmo payments platforms for US$800 million.
- PayPal in its acquisition of Zong SA, a Swiss mobile payments company.
- PayPal in its acquisition of Swift Financial, a leading provider of working capital solutions to small businesses.
- PayPal in numerous acquisitions, including, the acquisition of Modest, a mobile commerce platform; Israeli cybersecurity company CyActive; and mobile payments company, Card.io.
- eBay Inc. in the sale of Skype Technologies to Silver Lake Partners for US$2 billion.
- eBay Inc. in numerous acquisitions, including the acquisition of eCommerce company Milo; customer acquisition company Iron Pearl; and Israeli-based analytics company SalesPredict.
- HP Inc. in its sale of certain software assets to OpenText.
- Intuit Inc. in its acquisition of Exactor, a leading cloud-based SaaS technology provider.
- Internet Corporation for Assigned Names and Numbers (ICANN), a cross-community international working group in the historic transition of the oversight of ICANN and the internet domain name system from the U.S. government to a worldwide multistakeholder community.
Community Involvement
Membership & Activities
- American Bar Association
- State Bar of California; former Vice-Chair of the Corporations Committee
- Board of Trustees and Member of the Executive Committee of the Exploratorium
Credentials
- 美国加州
- 美国伊利诺州
- 美国哈佛大学法学院, 法学博士, 1996, cum laude
- Columbia University, 文学学士, 1992, summa cum laude, Phi Beta Kappa